Topics

Important story for @statnews subscribers: Three years after controversial approval of a therapy for Duchenne muscular dystrophy, there is still no clinical data confirming it's effective for patients. Via @adamfeuerstein http://bit.ly/2yXJeJM 

08:27 EDT 15 Aug 2019 | STAT

Important story for subscribers: Three years after controversial approval of a therapy for Duchenne muscular dystrophy, there is still no clinical data confirming it's effective for patients. Via http://bit.ly/2yXJeJM 

Original Article: Important story for @statnews subscribers: Three years after controversial approval of a therapy for Duchenne muscular dystrophy, there is still no clinical data confirming it's effective for patients. Via @adamfeuerstein http://bit.ly/2yXJeJM 

NEXT ARTICLE

More From BioPortfolio on "Important story for @statnews subscribers: Three years after controversial approval of a therapy for Duchenne muscular dystrophy, there is still no clinical data confirming it's effective for patients. Via @adamfeuerstein http://bit.ly/2yXJeJM "

Quick Search

Relevant Topic

Muscular Dystrophy
Muscular dystrophy is a group of degenerative inherited disorders causing muscle weakness and loss of muscle tissue. The different types are Becker muscular dystrophy, Duchenne muscular dystrophy, Emery-Dreifuss muscular dystrophy, Facioscapulohumeral mu...